General description
The pIE1-neo plasmid is designed for the establishment of stably-transformed insect cells. When co-transfected with a pIE1 vector containing a foreign gene under the control of the baculovirus ie1 promoter, stable cell lines that constitutively express low levels of the target gene can be selected in the presence of the antibiotic G418 (1). The neo gene is expressed from an "unenhanced" ie1 promoter in pIE1-neo.
Legal Information
NOVAGEN is a registered trademark of Merck KGaA, Darmstadt, Germany
Other Notes
1. Jarvis, D.L., Weinkauf, C. and Guarino, L.A. (1996) Prot. Exp. Pur. 8, 191–203.
Packaging
10 µg in Plastic ampoule
Warning
Toxicity: Standard Handling (A)
This product has met the following criteria to qualify for the following awards: